Nasopharyngeal Cancer

Our head and neck specialists offer evidence-based, compassionate care for people with nasopharyngeal cancer, which affects the nasopharynx, located at the top part of the throat. Through our clinical trials, we offer access to new imaging techniques that help your doctors diagnose nasopharyngeal cancer and guide treatment decisions. Then, our team of radiation oncologists, medical oncologists, and other experts develops a personalized care plan that’s right for you.

Clinical Trials and Research Studies

Phase 1

A Phase 1 Study of RTX-321 for the Treatment of Patients with Advanced Malignancies Associated with Human Papillomavirus-16 Infection

Learn More

Phase 1

Birinapant and Intensity Modulated Re-Irradiation Therapy (IMRRT) for Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)

Learn More

Phase 1

A Phase 1 First-in Human Multi-Center Open Label Dose-Escalation Study to Determine the Safety Tolerability Pharmacokinetics and RP2D of ABBV-151 as a Single Agent and in Combination with ABBV-181 in Subjects with Locally Advanced or Metastatic Solid Tumors (AbbVie M19-345)

Learn More

Phase 1

A Phase 1 Open Label Multi-Arm Multicenter Study of MK-4830 as Monotherapy and in Combination with Pembrolizumab for Participants with Advanced Solid Tumors

Learn More